Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).
货号（Catalog No.）
CSD00154
通用名INN
Panobacumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).
别名(Alternative names)
Aerumab 11,KBPA101
靶点;物种(Specificity target name;species)
Serotype IATS O12[Pseudomonas aeruginosa, Gram negative bacteria]
种类(Species)
Homo sapiens
受体鉴定(Receptor identification)
IgM-kappa
化学信息
CAS
885053-97-4
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
...
产品展厅
